Portfolio company
Presymptom Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bayesian Health
This company develops an artificial intelligence platform for hospitals to detect early signs of patient deterioration and life-threatening conditions such as sepsis.
Biocogniv
This company develops artificial intelligence software for hospital laboratories and emergency departments to predict time-critical conditions like sepsis from routine blood tests.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
GNOMX Corp
This company develops epigenetic diagnostic tests using artificial intelligence to identify infectious diseases and predict sepsis readmission risk for healthcare providers and clinicians.
20/20 BioLabs
This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
SurgeCare
The company develops AI-driven blood tests to predict postoperative infection risks for surgical teams and hospitals.
